Obstetrics & Gynecology, Gynecology · Silver Spring, MD
NPI
1730161522
Since 2005
Specialty
Obstetrics & Gynecology, Gynecology
Code 207VG0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
10801 Lockwood Dr, Ste 320
Silver Spring, MD, 20901
Phone (301) 681-3400
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
897 services
Medicare patients, 2024
434
Average age 73
Drug cost, 2024
$119K
681 prescriptions
Company payments, 2025
$501
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica Berger-Weiss was code G0101 (cervical or vaginal cancer screening; pelvic and clinical breast examination), 267 times for 267 patients. In total Jessica Berger-Weiss billed 897 services in 30 codes, and Medicare paid $50K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 267 | 267 | $44.17 | $12K |
| 99213 Office E&M - Established | Office | 221 | 198 | $67.82 | $15K |
| 96127 Behavioral Health Services | Office | 102 | 102 | $3.70 | $377 |
| 99214 Office E&M - Established | Office | 82 | 78 | $97.05 | $7,958 |
| 99459 Office/Outpatient Services | Office | 67 | 62 | $18.94 | $1,269 |
| 76830 Ultrasound - Abdomen and Pelvis | Office | 50 | 43 | $98.26 | $4,913 |
| 99212 Office E&M - Established | Office | 32 | 30 | $42.89 | $1,372 |
| 99203 Office E&M - New | Office | 13 | 13 | $77.05 | $1,002 |
| 90673 Vaccine Product | Office | 12 | 12 | $81.82 | $982 |
| G0008 Administration of influenza virus vaccine | Office | 11 | 11 | $35.85 | $394 |
By year: 2022 $46K for 597 services; 2023 $45K for 573 services; 2024 $50K for 897 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica Berger-Weiss prescribed most often to Medicare patients was Estradiol, with 191 prescriptions and refills. In total Jessica Berger-Weiss wrote 681 Medicare prescriptions that cost $119K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 191 | 471 | 89 | $23K |
| Progesterone Progesterone, Micronized | 50 | 148 | 15 | $2,724 |
| Yuvafem Estradiol | 39 | 112 | 14 | $10K |
| Valacyclovir Valacyclovir Hcl | 39 | 87 | 16 | $2,211 |
| Fluconazole Generic | 26 | 26 | 14 | $227 |
| Alendronate Sodium Generic | 25 | 70 | Under 11 | $170 |
| Estradiol (Once Weekly) Estradiol | 22 | 62 | Under 11 | $1,836 |
| Estradiol (Twice Weekly) Estradiol | 18 | 45 | Under 11 | $2,081 |
| Combipatch Estradiol/Norethindrone Acet | 18 | 33 | Under 11 | $7,814 |
| Estring Estradiol | 16 | 48 | Under 11 | $8,407 |
| Imvexxy Estradiol | 13 | 17 | Under 11 | $4,411 |
| Risedronate Sodium Generic | 12 | 36 | Under 11 | $876 |
| Clobetasol Propionate Generic | 12 | 12 | Under 11 | $445 |
| Escitalopram Oxalate Generic | 12 | 33 | Under 11 | $315 |
| Premarin Estrogens, Conjugated | 11 | 27 | Under 11 | $4,769 |
Brand drugs: 143 claims; generic drugs: 538 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica Berger-Weiss $501 ($501 in general payments such as food, travel and fees) from 10 companies. The largest payer was Mayne Pharma Commercial LLC with $120.
| Company | Payments | Amount |
|---|---|---|
| Mayne Pharma Commercial LLC | 5 | $120 |
| Astellas Pharma US Inc 4503.T | 4 | $115 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $73.34 |
| Amgen Inc. AMGN | 2 | $43.31 |
| Exeltis, USA Inc. | 2 | $40.09 |
| Sage Therapeutics, LLC SAGE | 2 | $35.97 |
| Meditrina | 1 | $21.95 |
| Supernus Pharmaceuticals, Inc. SUPN | 1 | $19.1 |
| Shield Therapeutics Inc STX.L | 1 | $16.83 |
| Millicent US Inc | 1 | $15.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.